PDGFRA and gastrointestinal stromal tumor: Prior in vivo and in vitro studies have shown promising results in GIST but also other cell lines (such as systemic mastocytosis, mast cell leukaemia, and germ cell tumours) transfected with KIT or PDGFRA mutants [13].